AAAAAA

   
Results: 1-10 |
Results: 10
Pharmacokinetic profile of 3 beta-hydroxy-17-(1H-1,2,3-triazol-1-yl)androsta-5,16-diene (VN/87-1), a potent androgen synthesis inhibitor, in mice
Authors: Nnane, IP Njar, VCO Brodie, AA
Citation: Ip. Nnane et al., Pharmacokinetic profile of 3 beta-hydroxy-17-(1H-1,2,3-triazol-1-yl)androsta-5,16-diene (VN/87-1), a potent androgen synthesis inhibitor, in mice, J STEROID B, 78(3), 2001, pp. 241-246
Potent inhibition of retinoic acid metabolism enzyme(s) by novel azolyl retinoids
Authors: Njar, VCO Nnane, IP Brodie, AMH
Citation: Vco. Njar et al., Potent inhibition of retinoic acid metabolism enzyme(s) by novel azolyl retinoids, BIOORG MED, 10(17), 2000, pp. 1905-1908
Pregnenolone stimulates LNCaP prostate cancer cell growth via the mutated androgen receptor
Authors: Grigoryev, DN Long, BJ Njar, VCO Brodie, AHM
Citation: Dn. Grigoryev et al., Pregnenolone stimulates LNCaP prostate cancer cell growth via the mutated androgen receptor, J STEROID B, 75(1), 2000, pp. 1-10
High-yield synthesis of novel imidazoles and triazoles from alcohols and phenols
Authors: Njar, VCO
Citation: Vco. Njar, High-yield synthesis of novel imidazoles and triazoles from alcohols and phenols, SYNTHESIS-S, (14), 2000, pp. 2019-2028
Aromatase inhibitors and their application in breast cancer treatment
Authors: Brodie, AMH Njar, VCO
Citation: Amh. Brodie et Vco. Njar, Aromatase inhibitors and their application in breast cancer treatment, STEROIDS, 65(4), 2000, pp. 171-179
Inhibitors of 17 alpha-hydroxylase/17,20-lyase (CYP17): Potential agents for the treatment of prostate cancer
Authors: Njar, VCO Brodie, AMH
Citation: Vco. Njar et Amh. Brodie, Inhibitors of 17 alpha-hydroxylase/17,20-lyase (CYP17): Potential agents for the treatment of prostate cancer, CUR PHARM D, 5(3), 1999, pp. 163-180
Effects of novel 17-azolyl compounds on androgen synthesis in vitro and invivo
Authors: Nnane, IP Njar, VCO Liu, Y Lu, Q Brodie, AMH
Citation: Ip. Nnane et al., Effects of novel 17-azolyl compounds on androgen synthesis in vitro and invivo, J STEROID B, 71(3-4), 1999, pp. 145-152
Comprehensive pharmacology and clinical efficacy of aromatase inhibitors
Authors: Njar, VCO Brodie, AMH
Citation: Vco. Njar et Amh. Brodie, Comprehensive pharmacology and clinical efficacy of aromatase inhibitors, DRUGS, 58(2), 1999, pp. 233-255
Effects of new 17 alpha-hydroxylase/C-17,C-20-lyase inhibitors on LNCaP prostate cancer cell growth in vitro and in vivo
Authors: Grigoryev, DN Long, BJ Nnane, IP Njar, VCO Liu, Y Brodie, AMH
Citation: Dn. Grigoryev et al., Effects of new 17 alpha-hydroxylase/C-17,C-20-lyase inhibitors on LNCaP prostate cancer cell growth in vitro and in vivo, BR J CANC, 81(4), 1999, pp. 622-630
Cytochrome P450c17-expressing Escherichia coli as a first-step screening system for 17 alpha-hydroxylase-C-17,C-20-lyase inhibitors
Authors: Grigoryev, DN Kato, K Njar, VCO Long, BJ Ling, YZ Wang, X Mohler, J Brodie, AMH
Citation: Dn. Grigoryev et al., Cytochrome P450c17-expressing Escherichia coli as a first-step screening system for 17 alpha-hydroxylase-C-17,C-20-lyase inhibitors, ANALYT BIOC, 267(2), 1999, pp. 319-330
Risultati: 1-10 |